SS Innovations

The SSI Mantra 3 improves precision, surgeon comfort, and patient outcomes in robotic surgery.

XR based Surgical Robotics Training and Patient Care Platform XR based Surgical Robotics Training and Patient Care Platform The Future

SSi Mudra develops robotic surgical instruments, including cardiothoracic applications.

SSI Sutra is a robotic surgery program by SS Innovations, designed around the SSI Mantra system to optimize robotic surgery for surgeons, staff, hospitals, and engineers.

SSI Mantra performs 25 complex surgical procedures at Rajiv Gandhi Cancer Institute and Research Center.

Dr. Sudhir Srivastava is a global expert in robotic cardiac surgery and has performed the most robotic cardiac procedures worldwide. He co-founded Alliance Hospital LTD with ten other physicians.

IMPROVING LIVES THROUGH INNOVATION AND CARE SS Innovations has been involved in the field of medical robotic technology over the past decade. Founder,Chairman and CEO, Dr. Sudhir Srivastava, has made it his

SS Innovations International Inc. is a medical technology company founded by Dr. Sudhir Srivastava, a robotic cardiac surgeon.

GitHubRepository owner

SS Innovations International responds to the FDA’s request for additional details about its **510(k) submission** for the **SSi Mantra**, a surgical robotic system. The company, which develops affordable robotic surgery technologies, submitted its response on **October 5, 2026**, addressing regulatory requirements. The FDA’s inquiry follows the company’s bid to expand access to robotic-assisted surgery globally.

Oct 2026BioSpaceNews article

SS Innovations secures regulatory approval for its **SSi Mantra surgical robotic system** in **Colombia, Oman, Sri Lanka, and Kenya**, expanding its reach across multiple indications. The company aims to make robotic surgery more affordable and accessible worldwide. Approval in these markets follows its mission to broaden global adoption of advanced surgical technologies.

Mar 2026nasdaq.comNews article

SS Innovations secures **$18.6 million** in funding to advance its surgical robot toward U.S. market entry. Fred Moll, co-founder of Intuitive Surgical, leads the round with a **$2 million** personal investment. The capital supports final regulatory and commercial preparations for deployment in American hospitals.

Mar 2026MedTech DiveNews article